speb/financial-data huggingface dataset:
DuPont ROE decomposition for CHCO (annual period ending 2025-12-31)
ROE: 16.942319378009067%
Net margin: 42.756313425059716%
Asset turnover: 0.04630482608284337
Equity multiplier (leverage): 8.557489106329495
Tax burden factor: 0.8081317932678909
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CHG.DE (annual period ending 2021-12-31)
ROE: -2.8037389879661845%
Net margin: -4.093178071445223%
Asset turnover: 0.27673273269329146
Equity multiplier (leverage): 2.4752348460980578
EBIT margin: -4.096144370104735%
ROE archetype: Low Return
DuPont ROE decomposition for CHG.DE (annual period ending 2022-12-31)
ROE: -8.599755544875347%
Net margin: -13.989559586662326%
Asset turnover: 0.3005956811542057
Equity multiplier (leverage): 2.0450283233036077
EBIT margin: -7.577857385665351%
ROE archetype: Low Return
DuPont ROE decomposition for CHG.DE (annual period ending 2023-12-31)
ROE: -3.8468211374235373%
Net margin: -5.771237374636621%
Asset turnover: 0.3666389412939417
Equity multiplier (leverage): 1.8180024580510705
EBIT margin: -7.226351307430601%
ROE archetype: Low Return
DuPont ROE decomposition for CHG.DE (annual period ending 2024-12-31)
ROE: -6.419180642741659%
Net margin: -10.363170143666771%
Asset turnover: 0.3735079467441144
Equity multiplier (leverage): 1.658391726995843
EBIT margin: -9.544292774049643%
ROE archetype: Low Return
DuPont ROE decomposition for CHG.DE (annual period ending 2025-12-31)
ROE: -11.562539742572302%
Net margin: -16.396637885032163%
Asset turnover: 0.36965007879876244
Equity multiplier (leverage): 1.9076892388346935
EBIT margin: -25.214208502101325%
ROE archetype: Low Return
DuPont ROE decomposition for CHG.L (quarterly period ending 2024-10-31)
Equity multiplier (leverage): 1.9424642155486949
ROE archetype: Standard Business
DuPont ROE decomposition for CHG.L (quarterly period ending 2025-04-30)
Equity multiplier (leverage): 2.0430743525480364
ROE archetype: Standard Business
DuPont ROE decomposition for CHG.L (quarterly period ending 2025-10-31)
Equity multiplier (leverage): 2.202743506493506
ROE archetype: Standard Business
DuPont ROE decomposition for CHG.L (quarterly period ending 2026-04-30)
Equity multiplier (leverage): 2.3607548161992
ROE archetype: Standard Business
DuPont ROE decomposition for CHI.L (annual period ending 2022-03-31)
ROE: 2.1435957379849837%
Net margin: 81.81194234728896%
Asset turnover: 0.02443441949387043
Equity multiplier (leverage): 1.072319381378411
Tax burden factor: 0.9900332225913621
ROE archetype: Low Return
DuPont ROE decomposition for CHI.L (annual period ending 2023-03-31)
ROE: -0.5235677881027526%
Asset turnover: -0.00012304970268925126
Equity multiplier (leverage): 1.0947502545137602
ROE archetype: Low Return
DuPont ROE decomposition for CHI.L (annual period ending 2024-03-31)
ROE: 10.720040711015768%
Net margin: 95.34409515717927%
Asset turnover: 0.0991681842976063
Equity multiplier (leverage): 1.1337838630708805
Tax burden factor: 0.9973338073231425
ROE archetype: Standard Business
DuPont ROE decomposition for CHI.L (annual period ending 2025-03-31)
ROE: 12.702634126278763%
Net margin: 96.4293071482524%
Asset turnover: 0.11495486819618818
Equity multiplier (leverage): 1.1459281157662624
Tax burden factor: 0.9977264653641207
ROE archetype: Standard Business
DuPont ROE decomposition for CHI.L (annual period ending 2026-03-31)
ROE: 16.52624690517236%
Net margin: 97.49567008378973%
Asset turnover: 0.147282536117865
Equity multiplier (leverage): 1.1509001708676152
Tax burden factor: 0.9999039846375422
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CHRS (quarterly period ending 2025-03-31)
Net margin: -744.426898276089%
Asset turnover: 0.02047883664900584
EBIT margin: -597.9076194236084%
ROE archetype: Standard Business
DuPont ROE decomposition for CHRS (quarterly period ending 2025-06-30)
Net margin: 2903.9106690072167%
Asset turnover: 0.02530196291315559
EBIT margin: -443.59274429490927%
ROE archetype: Standard Business
DuPont ROE decomposition for CHRS (quarterly period ending 2025-09-30)
ROE: -34.230085596890184%
Net margin: -307.06939763201103%
Asset turnover: 0.024207543439579992
Equity multiplier (leverage): 4.604905564038709
EBIT margin: -383.13888168697605%
ROE archetype: Low Return
DuPont ROE decomposition for CHRS (quarterly period ending 2025-12-31)
ROE: -50.599510713229556%
Net margin: -295.28553498588013%
Asset turnover: 0.032903923537352456
Equity multiplier (leverage): 5.207825899938167
EBIT margin: -359.8995920928773%
ROE archetype: Low Return
DuPont ROE decomposition for CHRS (quarterly period ending 2026-03-31)
ROE: -54.89519253492985%
Net margin: -311.34849715678314%
Asset turnover: 0.04695202769063534
Equity multiplier (leverage): 3.7552009854121757
EBIT margin: -293.6718115353371%
ROE archetype: Low Return
DuPont ROE decomposition for CHSR.PA (annual period ending 2021-12-31)
ROE: 5.898897621142711%
Net margin: 10.122425305820244%
Asset turnover: 0.4670714348954254
Equity multiplier (leverage): 1.247679301788958
EBIT margin: 18.26743849774842%
Interest burden factor: 0.5541239570653487
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CHSR.PA (annual period ending 2022-12-31)
ROE: 4.150925093176413%
Net margin: 7.334651419417572%
Asset turnover: 0.4608379261876852
Equity multiplier (leverage): 1.2280532644718254
EBIT margin: 6.8821550470506185%
Interest burden factor: 1.06574922669911
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CHSR.PA (annual period ending 2023-12-31)
ROE: 10.067769655645728%
Net margin: 21.713437460516957%
Asset turnover: 0.3918812325217101
Equity multiplier (leverage): 1.1831783741269704
EBIT margin: 20.069381317582547%
Interest burden factor: 1.081918626036273
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CHSR.PA (annual period ending 2024-12-31)
ROE: -0.6634234795857344%
Net margin: -1.5589679923566069%
Asset turnover: 0.36561618746168656
Equity multiplier (leverage): 1.1639336485019214
EBIT margin: -9.640622166213882%
ROE archetype: Low Return
DuPont ROE decomposition for CHSR.PA (annual period ending 2025-12-31)
ROE: 1.1199629603742924%
Net margin: 3.2053824918311693%
Asset turnover: 0.30073650043536226
Equity multiplier (leverage): 1.1618168149463346
EBIT margin: -37.938870306931314%
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CHSS.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 6.790770638535082
ROE archetype: Standard Business
DuPont ROE decomposition for CHSS.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 4.884227238375008
ROE archetype: Standard Business
DuPont ROE decomposition for CHSS.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 2.841472638267128
ROE archetype: Standard Business
DuPont ROE decomposition for CHYM (quarterly period ending 2025-03-31)
ROE: 1.3175942982657123%
Net margin: 2.494293909905464%
Asset turnover: 0.3612425913945623
Equity multiplier (leverage): 1.4622954592435773
EBIT margin: 1.7613697700599908%
Interest burden factor: 1.5859691364780562
Tax burden factor: 0.8928990407839349
ROE archetype: Low Return
DuPont ROE decomposition for CHYM (quarterly period ending 2025-06-30)
ROE: -76.62505731054327%
Net margin: -174.83248098547946%
Asset turnover: 0.3164015404647574
Equity multiplier (leverage): 1.3851924078311615
EBIT margin: -176.20747175512972%
ROE archetype: Low Return
DuPont ROE decomposition for CHYM (quarterly period ending 2025-09-30)
ROE: -3.8115576804398734%
Net margin: -10.068093295726552%
Asset turnover: 0.281267392623393
Equity multiplier (leverage): 1.3459715425239223
EBIT margin: -11.905747545164015%
ROE archetype: Low Return
DuPont ROE decomposition for CHYM (quarterly period ending 2025-12-31)
ROE: -3.1477901426372066%
Net margin: -7.508409378259367%
Asset turnover: 0.3037284219983315
Equity multiplier (leverage): 1.3802965222954116
EBIT margin: -9.016060822526066%
ROE archetype: Low Return
DuPont ROE decomposition for CHYM (quarterly period ending 2026-03-31)
ROE: 3.760338891960601%
Net margin: 8.257193919556617%
Asset turnover: 0.3307223419331043
Equity multiplier (leverage): 1.376990575235619
EBIT margin: 7.1306652744031%
Interest burden factor: 1.1678400450577302
Tax burden factor: 0.9915601639739571
ROE archetype: Low Return
DuPont ROE decomposition for CIA.TO (annual period ending 2023-03-31)
ROE: 15.895015775668728%
Net margin: 14.108790658014703%
Asset turnover: 0.6144283882348013
Equity multiplier (leverage): 1.8335801581368238
EBIT margin: 26.041374501165855%
Interest burden factor: 0.9354552227524996
Tax burden factor: 0.5791657649078764
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CIA.TO (annual period ending 2024-03-31)
ROE: 17.391849416536147%
Net margin: 14.779662856749775%
Asset turnover: 0.6254418227353256
Equity multiplier (leverage): 1.88145710081943
EBIT margin: 27.005349787226525%
Interest burden factor: 0.918006697623115
Tax burden factor: 0.5961682878213564
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CIA.TO (annual period ending 2025-03-31)
ROE: 9.841433039056941%
Net margin: 8.803003476084797%
Asset turnover: 0.5540033609206565
Equity multiplier (leverage): 2.017971689344422
EBIT margin: 19.756729840226523%
Interest burden factor: 0.8317189156634066
Tax burden factor: 0.5357216940037036
ROE archetype: Standard Business
DuPont ROE decomposition for CIA.TO (annual period ending 2026-03-31)
ROE: 11.831585241219948%
Net margin: 9.53455638173259%
Asset turnover: 0.5636346518420821
Equity multiplier (leverage): 2.201632159307423
EBIT margin: 17.435587668408363%
Interest burden factor: 0.9230497499700224
Tax burden factor: 0.592432386884302
ROE archetype: Standard Business
DuPont ROE decomposition for CIE1.DE (annual period ending 2022-10-31)
ROE: 5.636189985406551%
Net margin: 4.209090801481338%
Asset turnover: 0.7165531936045851
Equity multiplier (leverage): 1.8687400497113564
EBIT margin: 7.0810350869514105%
Interest burden factor: 0.7095012245850018
Tax burden factor: 0.8377962247609655
ROE archetype: Standard Business
DuPont ROE decomposition for CIE1.DE (annual period ending 2023-10-31)
ROE: 9.164424653430487%
Net margin: 5.809281966301984%
Asset turnover: 0.822134156963927
Equity multiplier (leverage): 1.9188457141254207
EBIT margin: 8.773480018119027%
Interest burden factor: 0.8409782436410785
Tax burden factor: 0.7873463246130887
ROE archetype: Standard Business
DuPont ROE decomposition for CIE1.DE (annual period ending 2024-10-31)
ROE: 2.9642868680884225%
Net margin: 2.0910819672947767%
Asset turnover: 0.7142248501089405
Equity multiplier (leverage): 1.9847884164159972
EBIT margin: 4.762419504079124%
Interest burden factor: 0.6268010397000141
Tax burden factor: 0.7005089695452649
ROE archetype: Low Return
DuPont ROE decomposition for CIE1.DE (annual period ending 2025-10-31)
ROE: 4.448250560232955%
Net margin: 2.5859695771491684%
Asset turnover: 0.8290466438217821
Equity multiplier (leverage): 2.074850765337634
EBIT margin: 6.5162290358311665%
Interest burden factor: 0.5028668691600814
Tax burden factor: 0.7891763230467025
ROE archetype: Low Return
DuPont ROE decomposition for CIFL.NS (annual period ending 2023-03-31)
ROE: -6.3342642721390785%
Net margin: -6.598904838824378%
Asset turnover: 0.3509892918300165
Equity multiplier (leverage): 2.7348306977896546
EBIT margin: -12.146094932593746%
ROE archetype: Low Return
DuPont ROE decomposition for CIFL.NS (annual period ending 2024-03-31)
ROE: 1.7566959904511057%
Net margin: 1.7940915030102533%
Asset turnover: 0.35830049212963316
Equity multiplier (leverage): 2.732779656541887
EBIT margin: -4.384509614527092%
Tax burden factor: 9.009049423776007
ROE archetype: Low Return
DuPont ROE decomposition for CIFL.NS (annual period ending 2025-03-31)
ROE: 0.23277239439698041%
Net margin: 0.2916058369404073%
Asset turnover: 0.28687943745556255
Equity multiplier (leverage): 2.7825042768314914
EBIT margin: -4.5738741067734106%
ROE archetype: Low Return
DuPont ROE decomposition for CIFL.NS (annual period ending 2026-03-31)
ROE: 5.512159668287583%
Net margin: 7.593200298640809%
Asset turnover: 0.2633878331438902
Equity multiplier (leverage): 2.75613967918784
EBIT margin: -9.691905615759238%
Tax burden factor: 1.0508377488185594
ROE archetype: Standard Business
DuPont ROE decomposition for CIG (annual period ending 2022-12-31)
ROE: 18.793609988982745%
Net margin: 9.369278652508239%
Asset turnover: 0.8141454416724115
Equity multiplier (leverage): 2.463780756518546
EBIT margin: 8.046503112413037%
Interest burden factor: 1.1717861205915814
Tax burden factor: 0.9936893203883496
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CIG (annual period ending 2023-12-31)
ROE: 25.82281727206457%
Net margin: 12.674725274725276%
Asset turnover: 0.8724826669700358
Equity multiplier (leverage): 2.3351149238912043
EBIT margin: 13.654945054945056%
Interest burden factor: 1.1026879124416549
Tax burden factor: 0.8417749233688512
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CIG (annual period ending 2024-12-31)
ROE: 24.214559123642537%
Net margin: 14.374558303886928%
Asset turnover: 0.7630413772953049
Equity multiplier (leverage): 2.207669046547198
EBIT margin: 16.03836446239273%
Interest burden factor: 1.178144277980612
Tax burden factor: 0.7607394742466339
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CIG (annual period ending 2025-12-31)
ROE: 18.535236228631256%
Net margin: 9.396758415651673%
Asset turnover: 0.8689904886741995
Equity multiplier (leverage): 2.269891198202152
EBIT margin: 12.137719382372685%
Interest burden factor: 0.8960176991150443
Tax burden factor: 0.864021164021164
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CIK (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.4510597384019042
ROE archetype: Standard Business
DuPont ROE decomposition for CIK (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.4839593531518684
ROE archetype: Standard Business
DuPont ROE decomposition for CIK (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.5323572950890831
ROE archetype: Standard Business
DuPont ROE decomposition for CIN.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.2270799635269898
ROE archetype: Standard Business
DuPont ROE decomposition for CIRSA.MC (quarterly period ending 2024-12-31)
ROE: 3.4965103948309504%
Net margin: 0.3568999396356287%
Asset turnover: 0.5308571398027063
Equity multiplier (leverage): 18.45485708648798
EBIT margin: 16.987309385275225%
Interest burden factor: 0.1932581339244963
Tax burden factor: 0.10871365476628635
ROE archetype: Low Return
DuPont ROE decomposition for CIRSA.MC (quarterly period ending 2025-03-31)
ROE: 15.129767039873862%
Net margin: 4.866021424088054%
Asset turnover: 0.1572100901965954
Equity multiplier (leverage): 19.777792104301103
EBIT margin: 15.11355321517372%
Interest burden factor: 0.4225893420524293
Tax burden factor: 0.7618840776435456
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CIRSA.MC (quarterly period ending 2025-09-30)
ROE: -1.1490035529492202%
Net margin: -0.8457072769274275%
Asset turnover: 0.17473171133299978
Equity multiplier (leverage): 7.775522343130477
EBIT margin: 11.8888362826375%
Interest burden factor: 0.2879994654550314
Tax burden factor: -0.246995499048768
ROE archetype: Low Return
DuPont ROE decomposition for CIRSA.MC (quarterly period ending 2025-12-31)
ROE: 10.232823452333676%
Net margin: 17.23711823421005%
Asset turnover: 0.12349191941117273
Equity multiplier (leverage): 4.807200983504545
EBIT margin: 43.18962854068795%
Interest burden factor: 0.49966702348594344
Tax burden factor: 0.7987382886929737
ROE archetype: Standard Business
DuPont ROE decomposition for CIRSA.MC (quarterly period ending 2026-03-31)
ROE: 5.172682045365519%
Net margin: 7.1593448222724465%
Asset turnover: 0.15834751538407396
Equity multiplier (leverage): 4.562798083446248
EBIT margin: 15.463677573453872%
Interest burden factor: 0.6247781180256397
Tax burden factor: 0.7410281119159966
ROE archetype: Standard Business
DuPont ROE decomposition for CIVB (annual period ending 2022-12-31)
ROE: 11.775053384502815%
Net margin: 28.77211162356238%
Asset turnover: 0.037651894725706805
Equity multiplier (leverage): 10.869368494930338
Tax burden factor: 0.8382481131072606
ROE archetype: Standard Business
DuPont ROE decomposition for CIVB (annual period ending 2023-12-31)
ROE: 12.15669241989313%
Net margin: 26.812448904448978%
Asset turnover: 0.042725483721006506
Equity multiplier (leverage): 10.611870912247095
Tax burden factor: 0.8488728192361646
ROE archetype: Standard Business
DuPont ROE decomposition for CIVB (annual period ending 2024-12-31)
ROE: 8.332106077022607%
Net margin: 20.85587898416209%
Asset turnover: 0.03816988859263957
Equity multiplier (leverage): 10.46659452152783
Tax burden factor: 0.8662711215617652
ROE archetype: Standard Business
DuPont ROE decomposition for CIVB (annual period ending 2025-12-31)
ROE: 9.916993570649888%
Net margin: 27.212182238945715%
Asset turnover: 0.04026616962195975
Equity multiplier (leverage): 9.050578555670961
Tax burden factor: 0.8366434326061374
ROE archetype: Standard Business
DuPont ROE decomposition for CKA.AX (annual period ending 2021-06-30)
ROE: -41.41768506429832%
Equity multiplier (leverage): 4.055488381643518
ROE archetype: Low Return
DuPont ROE decomposition for CKA.AX (annual period ending 2022-06-30)
ROE: -201.63492194515163%
Equity multiplier (leverage): 8.374388851949869
ROE archetype: Low Return
DuPont ROE decomposition for CKA.AX (annual period ending 2023-06-30)
ROE: -1395.9211579851135%
Equity multiplier (leverage): 56.327633019251614
ROE archetype: Low Return
DuPont ROE decomposition for CKA.AX (annual period ending 2024-06-30)
Net margin: -267.39222717533454%
Asset turnover: 0.08273168079591658
EBIT margin: -240.15914964899784%
ROE archetype: Standard Business
DuPont ROE decomposition for CKF.AX (quarterly period ending 2025-04-30)
Equity multiplier (leverage): 3.6589173105959674
ROE archetype: Standard Business
DuPont ROE decomposition for CL8.AX (annual period ending 2021-06-30)
ROE: -119.92732716531282%
Net margin: -336.72339281486626%
Asset turnover: 0.23194347559213488
Equity multiplier (leverage): 1.5355455553987447
EBIT margin: -351.736293633055%
ROE archetype: Low Return
DuPont ROE decomposition for CL8.AX (annual period ending 2022-06-30)
ROE: -168.66143023544933%
Net margin: -239.87835021451423%
Asset turnover: 0.3468374085228583
Equity multiplier (leverage): 2.0272102474533447
EBIT margin: -253.06792432062517%
ROE archetype: Low Return
DuPont ROE decomposition for CL8.AX (annual period ending 2023-06-30)
ROE: -596.8261546414526%
Net margin: -149.59905847895027%
Asset turnover: 0.4760330379351835
Equity multiplier (leverage): 8.380730818467388
EBIT margin: -149.8143000174726%
ROE archetype: Low Return
DuPont ROE decomposition for CL8.AX (annual period ending 2024-06-30)
Net margin: -116.03249653207737%
Asset turnover: 0.46106567849559066
EBIT margin: -101.57338413138606%
ROE archetype: Standard Business
DuPont ROE decomposition for CLARI.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 3.546767551510612
ROE archetype: Standard Business
DuPont ROE decomposition for CLARI.PA (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 3.616023100070908
ROE archetype: Standard Business
DuPont ROE decomposition for CLARI.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 3.6089845316733373
ROE archetype: Standard Business
DuPont ROE decomposition for CLB (annual period ending 2022-12-31)
ROE: 10.403590291817057%
Net margin: 4.014007575525539%
Asset turnover: 0.8467737752310869
Equity multiplier (leverage): 3.060819035320766
EBIT margin: 8.442729231114788%
Interest burden factor: 0.7244540111737248
Tax burden factor: 0.656272951859518
ROE archetype: Standard Business
DuPont ROE decomposition for CLB (annual period ending 2023-12-31)
ROE: 17.68311757780691%
Net margin: 7.262794484003217%
Asset turnover: 0.8753645635239867
Equity multiplier (leverage): 2.781417085163136
EBIT margin: 11.024343357068597%
Interest burden factor: 0.7332609740040212
Tax burden factor: 0.8984469788886192
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CLB (annual period ending 2024-12-31)
ROE: 13.338034742027482%
Net margin: 6.137849147080832%
Asset turnover: 0.894301017904014
Equity multiplier (leverage): 2.429919626652839
EBIT margin: 9.502947419862249%
Interest burden factor: 0.9278037805588477
Tax burden factor: 0.6961482668283283
ROE archetype: Standard Business
DuPont ROE decomposition for CLB (annual period ending 2025-12-31)
ROE: 11.587986105550534%
Net margin: 5.772050444427562%
Asset turnover: 0.9006962382606019
Equity multiplier (leverage): 2.228945752927405
EBIT margin: 9.588999468206335%
Interest burden factor: 0.9090476945016638
Tax burden factor: 0.6621709952937075
ROE archetype: Standard Business
DuPont ROE decomposition for CLFD (quarterly period ending 2025-03-31)
ROE: 0.4990616737934328%
Net margin: 3.2667831909603406%
Asset turnover: 0.13067423284661436
Equity multiplier (leverage): 1.169079236853091
EBIT margin: 4.140715393515669%
Interest burden factor: 1.944114149821641
Tax burden factor: 0.40581039755351683
ROE archetype: Low Return
DuPont ROE decomposition for CLFD (quarterly period ending 2025-06-30)
ROE: 0.6056092387461701%
Net margin: 3.2182433921808307%
Asset turnover: 0.15954486090218953
Equity multiplier (leverage): 1.1794805562102286
EBIT margin: 2.997815762579404%
Interest burden factor: 1.9906417112299466
Tax burden factor: 0.539288112827401
ROE archetype: Low Return
DuPont ROE decomposition for CLFD (quarterly period ending 2025-09-30)
ROE: -3.4872531639005144%
Net margin: -51.61767214419742%
Asset turnover: 0.056651575256529814
Equity multiplier (leverage): 1.192540320644439
EBIT margin: 24.64320236538352%
Interest burden factor: 1.4393170281495156
Tax burden factor: -1.4552741263225393
ROE archetype: Low Return
DuPont ROE decomposition for CLFD (quarterly period ending 2025-12-31)
ROE: -0.24277650919802696%
Net margin: -1.7879502635333857%
Asset turnover: 0.11960858412149984
Equity multiplier (leverage): 1.1352431224854937
EBIT margin: -5.311435310561719%
ROE archetype: Low Return
DuPont ROE decomposition for CLFD (quarterly period ending 2026-03-31)
ROE: -0.21443409502110836%
Net margin: -1.5352853944345906%
Asset turnover: 0.12938748713781303
Equity multiplier (leverage): 1.0794746364671983
EBIT margin: -6.016108865691605%
ROE archetype: Low Return
DuPont ROE decomposition for CLGN (annual period ending 2022-12-31)
ROE: -52.43022211207832%
Net margin: -5660.5351170568565%
Asset turnover: 0.007916754924804066
Equity multiplier (leverage): 1.1699761469595118
EBIT margin: -5718.060200668896%
ROE archetype: Low Return
DuPont ROE decomposition for CLGN (annual period ending 2023-12-31)
ROE: -22.81189370844971%
Net margin: -384.0306960183496%
Asset turnover: 0.050097156757760206
Equity multiplier (leverage): 1.1857204810658146
EBIT margin: -910.6042151524342%
ROE archetype: Low Return
DuPont ROE decomposition for CLGN (annual period ending 2024-12-31)
ROE: -79.01548320030385%
Net margin: -3225.048543689321%
Asset turnover: 0.019390493842376698
Equity multiplier (leverage): 1.2635344118939997
EBIT margin: -3349.7087378640776%
ROE archetype: Low Return
DuPont ROE decomposition for CLGN (annual period ending 2025-12-31)
ROE: -129.00182805795953%
Net margin: -484.5634753268663%
Asset turnover: 0.1750734981370694
Equity multiplier (leverage): 1.5206342907373527
EBIT margin: -484.31041754533953%
ROE archetype: Low Return
DuPont ROE decomposition for CLNN (quarterly period ending 2025-03-31)
Net margin: -927.1604938271604%
Asset turnover: 0.003199810381607016
EBIT margin: -4408.641975308642%
ROE archetype: Standard Business
DuPont ROE decomposition for CLNN (quarterly period ending 2025-06-30)
Net margin: -27477.777777777777%
Asset turnover: 0.0011383039271485487
EBIT margin: -20844.444444444445%
ROE archetype: Standard Business
DuPont ROE decomposition for CLNN (quarterly period ending 2025-09-30)
Net margin: -58513.333333333336%
Asset turnover: 0.0006751282743721307
EBIT margin: -35820%
ROE archetype: Standard Business
DuPont ROE decomposition for CLNN (quarterly period ending 2025-12-31)
Net margin: -11981.818181818182%
Asset turnover: 0.0038079224568517878
EBIT margin: -9407.792207792209%
ROE archetype: Standard Business
DuPont ROE decomposition for CLNN (quarterly period ending 2026-03-31)
Net margin: -53940%
Asset turnover: 0.000753844607498241
EBIT margin: -11280%
ROE archetype: Standard Business
DuPont ROE decomposition for CLPR (quarterly period ending 2025-03-31)
Net margin: -33.877354180415246%
Asset turnover: 0.031216647399576733
EBIT margin: 25.887100868064365%
Interest burden factor: -3.441808020394156
ROE archetype: Standard Business
DuPont ROE decomposition for CLPR (quarterly period ending 2025-06-30)
Net margin: -1.3218567476175838%
Asset turnover: 0.031186311768846123
EBIT margin: 27.728250845373502%
Interest burden factor: -0.12527716186252771
ROE archetype: Standard Business
DuPont ROE decomposition for CLPR (quarterly period ending 2025-09-30)
Net margin: -4.644808743169399%
Asset turnover: 0.030410331349027885
EBIT margin: 23.59541620245106%
Interest burden factor: -0.5179314221472737
ROE archetype: Standard Business
DuPont ROE decomposition for CLPR (quarterly period ending 2025-12-31)
Net margin: -11.559212301052064%
Asset turnover: 0.029988451978635148
EBIT margin: 21.726463447531696%
Interest burden factor: -1.3991805314129626
ROE archetype: Standard Business
DuPont ROE decomposition for CLPR (quarterly period ending 2026-03-31)
Net margin: -11.118982028072937%
Asset turnover: 0.03098383743545034
EBIT margin: 20.99435917617736%
Interest burden factor: -1.39265183704074
ROE archetype: Standard Business
DuPont ROE decomposition for CLPS (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.905799183659347
ROE archetype: Standard Business
DuPont ROE decomposition for CLPS (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.9197542116910171
ROE archetype: Standard Business
DuPont ROE decomposition for CLRO (quarterly period ending 2025-03-31)
ROE: -14.52290663113662%
Asset turnover: 0
Equity multiplier (leverage): 1.2646817669365584
ROE archetype: Low Return
DuPont ROE decomposition for CLRO (quarterly period ending 2025-06-30)
ROE: -26.535113174695297%
Net margin: -238.62212943632568%
Asset turnover: 0.07871169172623449
Equity multiplier (leverage): 1.412768427161927
EBIT margin: -237.94363256784968%
ROE archetype: Low Return
DuPont ROE decomposition for CLRO (quarterly period ending 2025-09-30)
ROE: -149.24756885967295%
Asset turnover: 0
Equity multiplier (leverage): 1.8187646004237519
ROE archetype: Low Return
DuPont ROE decomposition for CLRO (quarterly period ending 2025-12-31)
ROE: -359.81070258463774%
Asset turnover: 0
Equity multiplier (leverage): 4.285402257007645
ROE archetype: Low Return
DuPont ROE decomposition for CLRO (quarterly period ending 2026-03-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CLS.TO (quarterly period ending 2025-03-31)
ROE: 5.536998972250772%
Net margin: 3.254549573359511%
Asset turnover: 0.45392380332139365
Equity multiplier (leverage): 3.7480087358684484
EBIT margin: 5.010194064788945%
Interest burden factor: 0.8568198944988696
Tax burden factor: 0.7581354441512753
ROE archetype: Standard Business
DuPont ROE decomposition for CLS.TO (quarterly period ending 2025-06-30)
ROE: 12.987094040325717%
Net margin: 7.292458699108316%
Asset turnover: 0.4891143976216451
Equity multiplier (leverage): 3.6410576908384673
EBIT margin: 9.919126287412732%
Interest burden factor: 0.8965156794425087
Tax burden factor: 0.8200544111931597
ROE archetype: Standard Business
DuPont ROE decomposition for CLS.TO (quarterly period ending 2025-09-30)
ROE: 14.049767331340353%
Net margin: 8.384470882905449%
Asset turnover: 0.4937046112478696
Equity multiplier (leverage): 3.3941129266812737
EBIT margin: 10.32874139010645%
Interest burden factor: 0.9424067899363444
Tax burden factor: 0.8613702155033773
ROE archetype: Standard Business
DuPont ROE decomposition for CLS.TO (quarterly period ending 2025-12-31)
ROE: 12.690621704794275%
Net margin: 7.318941694711209%
Asset turnover: 0.5326002700160001
Equity multiplier (leverage): 3.2556164085736827
EBIT margin: 8.77725792771348%
Interest burden factor: 0.9392144638403991
Tax burden factor: 0.8878194490540989
ROE archetype: Standard Business
DuPont ROE decomposition for CLS.TO (quarterly period ending 2026-03-31)
ROE: 9.767982252794244%
Net margin: 5.245861131702496%
Asset turnover: 0.5195655279589104
Equity multiplier (leverage): 3.5838328275281177
EBIT margin: 6.6147763775636275%
Interest burden factor: 0.9574150168098617
Tax burden factor: 0.8283261802575108
ROE archetype: Standard Business
DuPont ROE decomposition for CM (quarterly period ending 2025-01-31)
ROE: 3.5225779234476207%
Net margin: 29.93656922228351%
Asset turnover: 0.006699529961273539
Equity multiplier (leverage): 17.563628693352396
Tax burden factor: 0.7671378091872791
ROE archetype: Low Return
DuPont ROE decomposition for CM (quarterly period ending 2025-04-30)
ROE: 3.3283110069691957%
Net margin: 28.728886344116805%
Asset turnover: 0.006589477787837168
Equity multiplier (leverage): 17.581426591536886
Tax burden factor: 0.7725173210161663
ROE archetype: Low Return
DuPont ROE decomposition for CM (quarterly period ending 2025-07-31)
ROE: 3.3583823364471006%
Net margin: 29.010380622837367%
Asset turnover: 0.006590956569017122
Equity multiplier (leverage): 17.56419541426992
Tax burden factor: 0.7708716439867598
ROE archetype: Low Return
DuPont ROE decomposition for CM (quarterly period ending 2025-10-31)
ROE: 3.4009295014807597%
Net margin: 28.874172185430464%
Asset turnover: 0.0067556451945258835
Equity multiplier (leverage): 17.434972032543754
Tax burden factor: 0.7808022922636103
ROE archetype: Low Return
DuPont ROE decomposition for CM (quarterly period ending 2026-01-31)
ROE: 4.854196545187787%
Net margin: 37.25513760365341%
Asset turnover: 0.007531596918816936
Equity multiplier (leverage): 17.29992083968652
Tax burden factor: 0.8854612967723507
ROE archetype: Low Return
DuPont ROE decomposition for CM (quarterly period ending 2026-04-30)
ROE: 3.7193222970619404%
Net margin: 30.947897049591965%
Asset turnover: 0.006896354915903961
Equity multiplier (leverage): 17.426616186783445
Tax burden factor: 0.7698313554028733
ROE archetype: Low Return
DuPont ROE decomposition for CMBTO.OL (quarterly period ending 2025-03-31)
ROE: 1.67743386702301%
Net margin: 18.71904834839434%
Asset turnover: 0.02855513870157727
Equity multiplier (leverage): 3.1381765083770654
EBIT margin: 23.955089259883255%
Interest burden factor: 0.6835982594796199
Tax burden factor: 1.1431021044427125
ROE archetype: Low Return
DuPont ROE decomposition for CMBTO.OL (quarterly period ending 2025-06-30)
ROE: 0.3122057334676312%
Net margin: 2.003053057182936%
Asset turnover: 0.04846292248449128
Equity multiplier (leverage): 3.2161687010279145
EBIT margin: 15.465127073190857%
Interest burden factor: -0.04770320967069612
ROE archetype: Low Return
DuPont ROE decomposition for CMBTO.OL (quarterly period ending 2025-09-30)
ROE: 0.7792010718720058%
Net margin: 4.3747028055159305%
Asset turnover: 0.054190662618424416
Equity multiplier (leverage): 3.2868245733009527
EBIT margin: 19.7306317254011%
Interest burden factor: 0.20265324794144557
Tax burden factor: 1.0940923856191158
ROE archetype: Low Return
DuPont ROE decomposition for CMBTO.OL (quarterly period ending 2025-12-31)
ROE: 3.4444595498006514%
Net margin: 15.120717172060171%
Asset turnover: 0.07023788136275896
Equity multiplier (leverage): 3.243226617537086
EBIT margin: 27.85052124011002%
Interest burden factor: 0.5824097443212992
Tax burden factor: 0.9322028575914586
ROE archetype: Low Return
DuPont ROE decomposition for CMBTO.OL (quarterly period ending 2026-03-31)
ROE: 13.11097171079732%
Net margin: 70.98012047033465%
Asset turnover: 0.06091782881388567
Equity multiplier (leverage): 3.0321712951055853
EBIT margin: 33.03696861228181%
Interest burden factor: 2.155367856934817
Tax burden factor: 0.9968163194707198
ROE archetype: Standard Business
DuPont ROE decomposition for CMCX.L (annual period ending 2022-03-31)
ROE: 19.377409333167066%
Net margin: 21.882911925251726%
Asset turnover: 0.5050061068938327
Equity multiplier (leverage): 1.7534523609431845
EBIT margin: 31.012757046683998%
Interest burden factor: 0.9031993761167215
Tax burden factor: 0.7812339472102301
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CMCX.L (annual period ending 2023-03-31)
ROE: 10.803204115898362%
Net margin: 12.745088993255148%
Asset turnover: 0.5097048895024222
Equity multiplier (leverage): 1.6629948708034328
EBIT margin: 19.152541851588712%
Interest burden factor: 0.8376637975334019
Tax burden factor: 0.7944136648582328
ROE archetype: Standard Business
DuPont ROE decomposition for CMCX.L (annual period ending 2024-03-31)
ROE: 12.205556158514758%
Net margin: 13.033120682705803%
Asset turnover: 0.5582624420844778
Equity multiplier (leverage): 1.6775317379279275
EBIT margin: 23.056331568194135%
Interest burden factor: 0.7635633680555556
Tax burden factor: 0.7403091595218922
ROE archetype: Standard Business
DuPont ROE decomposition for CMCX.L (annual period ending 2025-03-31)
ROE: 15.331250354783649%
Net margin: 17.26941757683304%
Asset turnover: 0.503392194268141
Equity multiplier (leverage): 1.7635728637998724
EBIT margin: 26.218067809130268%
Interest burden factor: 0.8945355943693002
Tax burden factor: 0.7363416771260095
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CMCX.L (annual period ending 2026-03-31)
ROE: 17.098707556696745%
Net margin: 17.75993808922127%
Asset turnover: 0.4841937115852377
Equity multiplier (leverage): 1.98839513664159
EBIT margin: 26.54615720847356%
Interest burden factor: 0.9118499190210546
Tax burden factor: 0.7336964565880228
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CMG.TO (annual period ending 2023-03-31)
ROE: 37.74451858913251%
Net margin: 26.808493351027813%
Asset turnover: 0.5385187561985882
Equity multiplier (leverage): 2.614451858913251
EBIT margin: 35.01882295588116%
Interest burden factor: 1.0304717710750193
Tax burden factor: 0.7429075352746923
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CMG.TO (annual period ending 2024-03-31)
ROE: 43.66856525173575%
Net margin: 24.161981615583507%
Asset turnover: 0.7009377741086631
Equity multiplier (leverage): 2.5784392799235025
EBIT margin: 31.270070574812063%
Interest burden factor: 1.0364289077212807
Tax burden factor: 0.7455283629549713
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CMG.TO (annual period ending 2025-03-31)
ROE: 28.447958886104203%
Net margin: 17.333096426309037%
Asset turnover: 0.6672922145747698
Equity multiplier (leverage): 2.4595683773507293
EBIT margin: 26.380112170325848%
Interest burden factor: 0.9630139393229472
Tax burden factor: 0.6822867568800365
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CMG.TO (annual period ending 2026-03-31)
ROE: 21.523155371139897%
Net margin: 13.80151994230876%
Asset turnover: 0.6367801999306866
Equity multiplier (leverage): 2.4490038762607487
EBIT margin: 21.432137508023676%
Interest burden factor: 0.8923645775559252
Tax burden factor: 0.7216375238253088
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CMI (quarterly period ending 2025-03-31)
ROE: 7.100492857739537%
Net margin: 10.398825544409101%
Asset turnover: 0.25126802127201747
Equity multiplier (leverage): 2.7174839194720573
EBIT margin: 12.27061414240274%
Interest burden factor: 1.1136590229312064
Tax burden factor: 0.7609668755595345
ROE archetype: Standard Business
DuPont ROE decomposition for CMI (quarterly period ending 2025-06-30)
ROE: 7.470616647882789%
Net margin: 10.737012611361795%
Asset turnover: 0.25881119928132956
Equity multiplier (leverage): 2.6883754628884238
EBIT margin: 12.8196228161518%
Interest burden factor: 1.105595667870036
Tax burden factor: 0.7575510204081632
ROE archetype: Standard Business
DuPont ROE decomposition for CMI (quarterly period ending 2025-09-30)
ROE: 4.304801509375842%
Net margin: 6.721173500060118%
Asset turnover: 0.2449887329337084
Equity multiplier (leverage): 2.6143390705017135
EBIT margin: 11.566670674522063%
Interest burden factor: 0.8627858627858628
Tax burden factor: 0.6734939759036145
ROE archetype: Low Return
DuPont ROE decomposition for CMI (quarterly period ending 2025-12-31)
ROE: 4.678186071078247%
Net margin: 7.2633552014995315%
Asset turnover: 0.2524323525062842
Equity multiplier (leverage): 2.5514977740888853
EBIT margin: 9.149484536082474%
Interest burden factor: 1.0128040973111396
Tax burden factor: 0.7838179519595448
ROE archetype: Low Return
DuPont ROE decomposition for CMI (quarterly period ending 2026-03-31)
ROE: 5.078416728902166%
Net margin: 8.097165991902834%
Asset turnover: 0.24542279760948024
Equity multiplier (leverage): 2.5555265123226287
EBIT margin: 11.907597046915933%
Interest burden factor: 0.934
Tax burden factor: 0.728051391862955
ROE archetype: Standard Business
DuPont ROE decomposition for CMIL.V (quarterly period ending 2024-11-30)
ROE: -57.73278235212972%
Asset turnover: 0
Equity multiplier (leverage): 3.5457102324786542
ROE archetype: Low Return
DuPont ROE decomposition for CMIL.V (quarterly period ending 2025-02-28)
ROE: -27.861329693822096%
Asset turnover: 0
Equity multiplier (leverage): 3.7201075085091593
ROE archetype: Low Return
DuPont ROE decomposition for CMIL.V (quarterly period ending 2025-08-31)
ROE: -116.13603992396335%
Asset turnover: 0
Equity multiplier (leverage): 27.517702115471717
ROE archetype: Low Return
DuPont ROE decomposition for CMIL.V (quarterly period ending 2025-11-30)
ROE: -146.35049410084048%
Asset turnover: 0
Equity multiplier (leverage): 6.591025626017465
ROE archetype: Low Return
DuPont ROE decomposition for CMIL.V (quarterly period ending 2026-02-28)
ROE: -70.72433702700955%
Asset turnover: 0
Equity multiplier (leverage): 2.5375534041065833
ROE archetype: Low Return
DuPont ROE decomposition for CMPG.L (annual period ending 2022-05-31)
ROE: -8.37472051906733%
Asset turnover: -0.07547699549587221
Equity multiplier (leverage): 1.0484183101502464
ROE archetype: Low Return
DuPont ROE decomposition for CMPG.L (annual period ending 2023-05-31)
ROE: -6.868488522517229%
Asset turnover: -0.06081433879428145
Equity multiplier (leverage): 1.0551502576556095
ROE archetype: Low Return
DuPont ROE decomposition for CMPG.L (annual period ending 2024-05-31)
ROE: 9.764830397342035%
Net margin: 95.62678346273806%
Asset turnover: 0.09671536034977585
Equity multiplier (leverage): 1.0558195573186535
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CMPG.L (annual period ending 2025-05-31)
ROE: 3.1047278504182105%
Net margin: 86.03341467993243%
Asset turnover: 0.03439088451518212
Equity multiplier (leverage): 1.0493322756053203
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CMW.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.5615929568746132
ROE archetype: Standard Business
DuPont ROE decomposition for CN.V (annual period ending 2022-02-28)
ROE: 1.9302024655265044%
Asset turnover: 0
Equity multiplier (leverage): 1.0229097695587461
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CN.V (annual period ending 2023-02-28)
ROE: 6.446998317691327%
Asset turnover: 0
Equity multiplier (leverage): 1.0214569928441233
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CN.V (annual period ending 2024-02-29)
ROE: 14.046039125225967%
Asset turnover: 0
Equity multiplier (leverage): 1.015683704722177
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CN.V (annual period ending 2025-02-28)
ROE: -56.79099084618699%
Asset turnover: 0
Equity multiplier (leverage): 1.0214791677016941
ROE archetype: Low Return
DuPont ROE decomposition for CN.V (annual period ending 2026-02-28)
ROE: -26.489116956434263%
Asset turnover: 0
Equity multiplier (leverage): 1.0642854883673771
ROE archetype: Low Return
DuPont ROE decomposition for CNH (annual period ending 2022-12-31)
ROE: 29.228784403669746%
Net margin: 8.65780646257059%
Asset turnover: 0.5980295066148651
Equity multiplier (leverage): 5.645212155963306
EBIT margin: 17.56188696870621%
Interest burden factor: 0.6484526112185686
Tax burden factor: 0.7602535421327368
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CNH (annual period ending 2023-12-31)
ROE: 30.9267046500602%
Net margin: 9.263985093368978%
Asset turnover: 0.5895394504017977
Equity multiplier (leverage): 5.662691824555172
EBIT margin: 20.030785433629035%
Interest burden factor: 0.5466127401415571
Tax burden factor: 0.8460969293377728
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CNH (annual period ending 2024-12-31)
ROE: 15.716710174515983%
Net margin: 6.347045775357935%
Asset turnover: 0.4418523045108696
Equity multiplier (leverage): 5.604190501172497
EBIT margin: 19.409155071587016%
Interest burden factor: 0.37844155844155847
Tax burden factor: 0.8641043239533288
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CNH (annual period ending 2025-12-31)
ROE: 6.795288599904066%
Net margin: 2.818458137607074%
Asset turnover: 0.4388793236480343
Equity multiplier (leverage): 5.493526155199062
EBIT margin: 15.501519756838908%
Interest burden factor: 0.2210338680926916
Tax burden factor: 0.8225806451612904
ROE archetype: Standard Business
DuPont ROE decomposition for CNI.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.382701591019452
ROE archetype: Standard Business
DuPont ROE decomposition for CNP (annual period ending 2022-12-31)
ROE: 10.522648083623693%
Net margin: 11.339984980152344%
Asset turnover: 0.24181497431640117
Equity multiplier (leverage): 3.837332005973121
EBIT margin: 16.800772449308013%
Interest burden factor: 0.9048531289910601
Tax burden factor: 0.7459421312632322
ROE archetype: Standard Business
DuPont ROE decomposition for CNP (annual period ending 2023-12-31)
ROE: 9.303977272727272%
Net margin: 10.545078196872124%
Asset turnover: 0.22223074072654322
Equity multiplier (leverage): 3.970221185064935
EBIT margin: 20.239190432382706%
Interest burden factor: 0.6176136363636363
Tax burden factor: 0.84360625574977
ROE archetype: Standard Business
DuPont ROE decomposition for CNP (annual period ending 2024-12-31)
ROE: 10.023115133034969%
Net margin: 11.789887770450076%
Asset turnover: 0.2070601200244361
Equity multiplier (leverage): 4.1057886194855655
EBIT margin: 23.024412819622817%
Interest burden factor: 0.6100502512562814
Tax burden factor: 0.8393739703459637
ROE archetype: Standard Business
DuPont ROE decomposition for CNP (annual period ending 2025-12-31)
ROE: 9.642971721893764%
Net margin: 11.24291973923266%
Asset turnover: 0.20723793492945894
Equity multiplier (leverage): 4.138686465924194
EBIT margin: 22.549962594848775%
Interest burden factor: 0.5909952606635072
Tax burden factor: 0.8436246992782679
ROE archetype: Standard Business
DuPont ROE decomposition for CNTN (quarterly period ending 2025-03-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CNTN (quarterly period ending 2025-06-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CNTN (quarterly period ending 2025-09-30)
ROE: -64.45194908578198%
Asset turnover: 0
Equity multiplier (leverage): 1.5684226116826474
ROE archetype: Low Return
DuPont ROE decomposition for CNTN (quarterly period ending 2025-12-31)
ROE: -14.56023734387299%
Asset turnover: 0
Equity multiplier (leverage): 1.303813332023298
ROE archetype: Low Return
DuPont ROE decomposition for CNTN (quarterly period ending 2026-03-31)
ROE: -10.912025399082626%
Asset turnover: 0
Equity multiplier (leverage): 1.2720629187029786
ROE archetype: Low Return
DuPont ROE decomposition for CNXN (annual period ending 2022-12-31)
ROE: 11.64472868469997%
Net margin: 2.8550116544149176%
Asset turnover: 2.841354905230464
Equity multiplier (leverage): 1.4354762293209775
EBIT margin: 4.079269221464603%
Interest burden factor: 0.9541721251676774
Tax burden factor: 0.7334977596908785
ROE archetype: Standard Business
DuPont ROE decomposition for CNXN (annual period ending 2023-12-31)
ROE: 10.363908591598204%
Net margin: 2.9211294009353677%
Asset turnover: 2.4915962585552793
Equity multiplier (leverage): 1.423951206701922
EBIT margin: 3.9477395283311423%
Interest burden factor: 1.005136134214829
Tax burden factor: 0.7361688208356172
ROE archetype: Standard Business
DuPont ROE decomposition for CNXN (annual period ending 2024-12-31)
ROE: 9.943730780011155%
Net margin: 3.1081845946530446%
Asset turnover: 2.252746373709418
Equity multiplier (leverage): 1.4201370395551438
EBIT margin: 3.7184015805187363%
Interest burden factor: 1.1275793231855962
Tax burden factor: 0.7413160605003106
ROE archetype: Standard Business
DuPont ROE decomposition for CNXN (annual period ending 2025-12-31)
ROE: 9.194561588473027%
Net margin: 2.9143544190819517%
Asset turnover: 2.1678819475232607
Equity multiplier (leverage): 1.4553016824811105
EBIT margin: 3.878867118777644%
Interest burden factor: 1.0206228125280445
Tax burden factor: 0.7361599606077659
ROE archetype: Standard Business
DuPont ROE decomposition for COAG (annual period ending 2024-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for COAG (annual period ending 2025-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for COB.AX (annual period ending 2021-06-30)
ROE: -8.216070388423924%
Equity multiplier (leverage): 1.133970998497808
ROE archetype: Low Return
DuPont ROE decomposition for COB.AX (annual period ending 2022-06-30)
ROE: -13.53541745754168%
Equity multiplier (leverage): 1.1737681408576923
ROE archetype: Low Return
DuPont ROE decomposition for COB.AX (annual period ending 2023-06-30)
ROE: -9.987390952781839%
Equity multiplier (leverage): 1.1777419575117438
ROE archetype: Low Return
DuPont ROE decomposition for COB.AX (annual period ending 2024-06-30)
ROE: -75.3731667784726%
Net margin: -50126.666666666664%
Asset turnover: 0.001283445222557901
Equity multiplier (leverage): 1.1715763572469655
EBIT margin: -51854.666666666664%
ROE archetype: Low Return
DuPont ROE decomposition for COFFEEDAY.NS (annual period ending 2022-03-31)
ROE: -3.195170024054509%
Net margin: -20.861368157052667%
Asset turnover: 0.09173183807977965
Equity multiplier (leverage): 1.6696717142281892
EBIT margin: -22.276225892934356%
ROE archetype: Low Return
DuPont ROE decomposition for COFFEEDAY.NS (annual period ending 2023-03-31)
ROE: -10.17843638627937%
Net margin: -41.44704534293665%
Asset turnover: 0.1446193161558851
Equity multiplier (leverage): 1.6980918863701007
EBIT margin: 0.6755060839198996%
Interest burden factor: -61.772213247172864
ROE archetype: Low Return
DuPont ROE decomposition for COFFEEDAY.NS (annual period ending 2024-03-31)
ROE: -9.375002488609713%
Net margin: -30.52444497398626%
Asset turnover: 0.18238168304021757
Equity multiplier (leverage): 1.6840012000863487
EBIT margin: 3.8285873148258465%
Interest burden factor: -9.568205394190873
ROE archetype: Low Return
DuPont ROE decomposition for COFFEEDAY.NS (annual period ending 2025-03-31)
ROE: -1.8859323669696955%
Net margin: -5.425335052991644%
Asset turnover: 0.21033287830688346
Equity multiplier (leverage): 1.652693750932795
EBIT margin: 1.120581693115759%
Interest burden factor: -0.9983319432860719
ROE archetype: Low Return
DuPont ROE decomposition for COFORGE.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.5188246787405126
ROE archetype: Standard Business
DuPont ROE decomposition for COFORGE.NS (quarterly period ending 2024-12-31)
Net margin: 7.854270894079372%
EBIT margin: 9.778705380436453%
Interest burden factor: 1.0677966101694913
Tax burden factor: 0.7522045855379189
ROE archetype: Standard Business
DuPont ROE decomposition for COFORGE.NS (quarterly period ending 2025-03-31)
ROE: 3.6895185496458165%
Net margin: 8.979603763660805%
Asset turnover: 0.2739798410017053
Equity multiplier (leverage): 1.4996638251890984
EBIT margin: 12.223131319034538%
Interest burden factor: 0.940234281616065
Tax burden factor: 0.7813374014747013
ROE archetype: Low Return
DuPont ROE decomposition for COFORGE.NS (quarterly period ending 2025-06-30)
Net margin: 9.662202461638563%
EBIT margin: 10.654448842379223%
Interest burden factor: 0.9297709923664121
Tax burden factor: 0.975369458128079
ROE archetype: Standard Business